Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs SCHLX overlap: 70% of top holdings shared

Bottom line

How much do PHSYX and SCHLX overlap?

70% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 69.0% of PHSYX's assets and 61.8% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PHSYXSCHLX
Weight overlap (top 25)70%
Shared holdings16
Weight in shared holdings69.0%61.8%
Total positions11565
Expense ratio0.79%1.06%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings PHSYX and SCHLX have in common

Holding% of PHSYX% of SCHLXOverlap
Eli Lilly & Co.13.15%13.85%13.15%
Johnson & Johnson8.46%6.19%6.19%
UnitedHealth Group, Inc.6.93%5.73%5.73%
AbbVie, Inc.6.05%4.90%4.90%
Merck & Co., Inc.4.88%4.85%4.85%
AstraZeneca plc4.67%3.80%3.80%
Thermo Fisher Scientific, Inc.4.50%3.46%3.46%
Intuitive Surgical, Inc.4.04%2.69%2.69%
Roche Holding AG2.79%1.24%1.24%
Gilead Sciences, Inc.2.63%2.78%2.63%
McKesson Corp.2.14%2.05%2.05%
Cardinal Health, Inc.2.12%1.34%1.34%
Vertex Pharmaceuticals, Inc.1.97%2.45%1.97%
Boston Scientific Corp.1.80%2.10%1.80%
Bristol-Myers Squibb Co.1.75%1.50%1.50%
Amgen, Inc.1.11%2.88%1.11%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. Novartis AG — 5.13%
  2. Sanofi SA — 3.23%
  3. Edwards Lifesciences Corp. — 2.80%
  4. CVS Health Corp. — 2.74%
  5. Novo Nordisk A/S — 1.90%
  6. Dexcom, Inc. — 1.64%
  7. Hoya Corp. — 1.52%
  8. Putnam Short Term Investment Fund — 1.35%
  9. HCA Healthcare, Inc. — 1.18%

Only in SCHLX

  1. Novartis AG — 2.90%
  2. Stryker Corp — 2.61%
  3. Abbott Laboratories — 2.39%
  4. Danaher Corp — 2.13%
  5. Novo Nordisk A/S — 1.73%
  6. Medtronic PLC — 1.54%
  7. Regeneron Pharmaceuticals Inc — 1.43%
  8. Cencora Inc — 1.26%
  9. Pfizer Inc — 1.17%

Asset mix

Asset typePHSYXSCHLX
Stocks98.2%99.6%
Other1.4%—
Cash & short-term funds0.6%0.5%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryPHSYXSCHLX
US76.2%85.7%
CH7.9%5.2%
GB6.4%3.8%
FR3.2%1.0%
DK2.4%1.7%
JP2.4%—
IE—1.5%
NL1.2%1.0%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PHSYX and SCHLX overlap?
About 70% by weight. 16 securities appear in both funds' top 25 holdings; they make up 69.0% of PHSYX's assets and 61.8% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co., Johnson & Johnson, UnitedHealth Group, Inc., AbbVie, Inc., Merck & Co., Inc..
Should I own both PHSYX and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or SCHLX?
PHSYX is broader, with 115 positions versus 65 for SCHLX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.